Last updated: June 14, 2026
Back to directoryAI platforms for genomics, oncology, real-world data, multimodal clinical data, and personalized medicine workflows.
| Regulatory / FDA | Verify lab, diagnostic, companion-diagnostic, research, and software status for the selected test, model, or report. |
|---|---|
| Privacy | Review genomic, imaging, EHR, and real-world data rights, consent, de-identification, retention, and secondary-use terms. |
| Evidence | Check validation population, biomarker evidence, model explainability, clinical utility, and how uncertainty appears in reports. |
| Workflow | Define how reports enter tumor boards, molecular pathology review, trial matching, treatment planning, and patient counseling. |
| Product | Best fit | First verification check | Official sources |
|---|---|---|---|
| Prenosis Sepsis ImmunoScore | Hospitals evaluating transparent sepsis risk stratification that combines clinical data and biomarkers with EMR-integrated review for suspected sepsis workflows. | FDA De Novo DEN230036 intended use, patient eligibility, blood-culture-order requirement, 24-hour risk window, and prescription-use limits. | 4 official sources |
| Cytovale IntelliSep | Hospitals that want a rapid, lab-run host-response signal to support supervised ED sepsis triage, protocol decisions, and stewardship review. | FDA 510(k) K220991 intended use, any subsequent IntelliSep clearances, adult ED suspected-infection population, prescription-use status, sample requirements, and three-day sepsis-with-organ-dysfunction window. | 6 official sources |
| Anumana ECG-AI | Health systems evaluating FDA-cleared cardiac detection support that can fit existing ECG, EHR, and cardiology referral workflows. | Which ECG-AI algorithm is in scope: low ejection fraction, pulmonary hypertension, cardiac amyloidosis, or another pipeline module. | 6 official sources |
| Eko Health SENSORA | Health systems and clinics that want to add clinician-reviewed cardiac disease detection signals to routine intake, primary care, or outpatient cardiovascular screening workflows. | Which SENSORA algorithm, device, software version, compatible stethoscope, patient population, geography, and FDA-cleared indication are in scope. | 6 official sources |
| AliveCor Kardia 12L | Clinical teams that need portable 12-lead ECG acquisition with AI-supported cardiac findings in supervised, trained-user workflows. | Which Kardia 12L device, KAI 12L algorithm version, cardiac determinations, geography, and labeling are in scope for the deployment. | 6 official sources |
| Philips Cardiologs Holter | Cardiology and ambulatory monitoring teams that need AI-supported ECG review while preserving clinician overread, annotation, reporting, and escalation workflows. | Which product is in scope: Cardiologs Holter Platform, Philips Holter Analysis System, API integration, supported ECG source, algorithm version, and geography. | 6 official sources |
| Tempus | Oncology and life-sciences teams evaluating AI-enabled precision medicine workflows that combine molecular, clinical, imaging, and real-world data. | Which Tempus product is in scope: One, Hub, Now, Lens, Pixel, Next Pathways, Next Trials, assays, or algos. | 5 official sources |
| Tempus One | Oncology and precision-medicine teams that need governed access to Tempus patient insights, test status, guideline context, trial matching, and multimodal data summaries. | Whether Tempus One is being used in Hub, an EHR integration, Lens, a provider workflow, or a life-sciences research workflow. | 6 official sources |
| SOPHiA GENETICS | Labs and health systems that need standardized analytics for precision oncology, rare disease, and multimodal data workflows. | Whether the selected module is diagnostic, research, or local-validation use. | 3 official sources |
| Guardant InfinityAI | Organizations exploring clinical-genomic oncology cohorts, biomarker hypotheses, testing value, and longitudinal cancer data strategy. | Which InfinityAI module, data library, or Guardant product feature is being evaluated. | 3 official sources |
| ArteraAI Prostate | Prostate cancer programs that need an FDA-authorized, clinician-ordered AI risk-stratification input tied to pathology images, clinical data, and guideline-aware decision workflows. | Whether the patient population matches the localized, non-metastatic, post-radical-prostatectomy, or metastatic hormone-sensitive prostate workflow being considered. | 5 official sources |
| Avenda Unfold AI | Prostate cancer teams evaluating a regulated, physician-reviewed mapping input for focal therapy suitability, biopsy planning, ablation planning, or shared treatment decisions. | FDA 510(k) K221624, current labeling, indications for use, trained-user requirements, and whether the evaluated product version is Unfold AI or an older iQuest-branded release. | 6 official sources |
| Unlearn | Sponsors exploring smaller or more informative control arms, single-arm study context, interim looks, or trial power improvements with statistical review. | Which disease-specific Digital Twin Generator and study design are in scope. | 4 official sources |
| Owkin K Pro | Research teams that need governed analysis across genomic, transcriptomic, spatial, clinical, and literature data for discovery or biomarker work. | Which datasets, AI skills, and biomedical tasks are available for the research question. | 3 official sources |
| Caris Life Sciences | Oncology teams evaluating molecular profiling and AI-assisted insight workflows for cancer care and research. | Which test, report, or AI insight is being used and its exact clinical role. | 3 official sources |
| Flatiron Assist | Oncology teams that need EHR-embedded pathway support tied to NCCN content, local preferences, biomarker context, and operational reporting. | Which cancers, regimens, biomarkers, pathways, and clinical-trial workflows are supported. | 2 official sources |
| Truveta | Research and evidence teams that need daily updated EHR, claims, mortality, imaging, multiomics, and other linked data with reproducibility controls. | Which Truveta product is in scope: Data, Studio, Intelligence, Evidence, Tru, or Truveta Language Model-supported workflows. | 6 official sources |
| Deep 6 AI | Research organizations that need faster protocol feasibility and patient identification while maintaining investigator, IRB, privacy, and site-review controls. | Which workflow is in scope: cohort discovery, site feasibility, patient matching, chart abstraction, sponsor search, or network analytics. | 4 official sources |
| Dyania Health Synapsis | Research organizations that need faster chart review and eligibility screening while preserving study-team, clinician, IRB, and privacy controls. | Which Synapsis workflow is in scope: trial screening, protocol feasibility, registry abstraction, chart review, or real-world evidence extraction. | 4 official sources |
| TriNetX | Research organizations that need cohort feasibility, site intelligence, and real-world data analytics before launching or adapting clinical trials. | Which TriNetX module, dataset, geography, and trial workflow are in scope: feasibility, protocol design, site identification, recruitment planning, or RWE. | 4 official sources |
| Medidata AI | Sponsors and CROs that already manage regulated trial operations and need auditable AI support across study design, execution, data oversight, and evidence planning. | Which Medidata AI capability is in scope: Dot, protocol optimization, study feasibility, integrated evidence, synthetic control arm, data management, or operational monitoring. | 4 official sources |
| ConcertAI | Oncology sponsors, CROs, research networks, and cancer programs that need governed real-world evidence or trial intelligence built around oncology data. | Which ConcertAI product is in scope: PrecisionExplorer, PrecisionTRIALS, PrecisionGTM, Precision360, CancerLinQ, or a trial operations workflow. | 3 official sources |
| Aetion Evidence Platform | Evidence teams that need guardrailed, auditable RWE workflows across claims, EHR, registry, or other longitudinal datasets. | Which Aetion product is being used: Evidence Platform, Discover, Activate, Substantiate, Generate, Science and Research services, or AetionAI-supported workflows. | 4 official sources |
| nference nSights | Research teams exploring patient cohorts, multimodal data signals, drug or diagnostic development questions, and code-free RWE workflows. | Which nSights application, dataset, modality, institution source, or analytics tier is available for the research question. | 4 official sources |
| Dandelion Health | Teams that need representative multimodal clinical data, AI-derived labels, algorithm validation, bias assessment, or real-world evidence before development, regulatory, or commercial decisions. | Which workflow is in scope: Dandelion Data, Clinical AI Marketplace, AI developer validation, life-sciences evidence generation, or a disease-specific data library. | 6 official sources |
| KidneyIntelX.dkd | Care teams that need a regulated kidney-risk stratification workflow with lab operations, clinician review, and treatment-planning follow-through. | Whether the patient population matches the FDA-authorized intended use for adults with type 2 diabetes and early-stage chronic kidney disease. | 5 official sources |
| Healthy.io Minuteful Kidney | Payers and care teams trying to close kidney health testing gaps for people with diabetes, hypertension, or other CKD risk factors without requiring a lab visit. | Whether the patient population, state, health-plan arrangement, prescription workflow, and smartphone requirements match the current Minuteful Kidney terms. | 5 official sources |
| Roche Kidney Klinrisk Algorithm | European or UK care pathways that need integrated CKD risk stratification for adults with CKD stages G1-G4 or adults with diabetes or hypertension at risk for CKD. | Whether Kidney Klinrisk Algorithm is available and certified for the deployment country, patient group, outpatient setting, and navify Algorithm Suite configuration. | 5 official sources |
| CancerIQ | Cancer prevention and genetics programs that need an EHR-connected workflow to collect family-history data, identify eligible patients, route navigation, and monitor follow-through. | Which CancerIQ modules are in scope, including patient questionnaires, hereditary cancer risk assessment, provider dashboards, navigator workflows, specialist review, analytics, virtual care, EHR integration, or registry functionality. | 5 official sources |
| Freenome SimpleScreen CRC | Health systems evaluating whether an easier blood-draw screening option could improve average-risk CRC screening participation while preserving guideline-based follow-up and colonoscopy pathways. | Current FDA, CLIA, state laboratory, payer, guideline, and local medical-policy status for SimpleScreen CRC at the time of ordering. | 5 official sources |
| GRAIL Galleri | Programs evaluating supervised cancer-screening access for adults at elevated cancer risk while preserving routine recommended screening, confirmatory diagnostic workflows, and oncology follow-up capacity. | Current FDA, CLIA, CAP, payer, guideline, state laboratory, health-system policy, and medical-necessity status before offering or ordering the test. | 7 official sources |
| Rune Labs StrivePD | Parkinson's programs that want longitudinal patient-generated data, tremor and dyskinesia summaries, medication and symptom tracking, clinician visit preparation, and supervised AI-supported care coaching. | Which workflow is in scope: free patient app, Apple Watch movement-disorder measures, clinician dashboard, StrivePD Guardian AI companion, Guardian Premier human support, payor program, or trial data collection. | 6 official sources |
| Google Cloud Agent Search for Healthcare | Organizations already building on Google Cloud that need a configurable search layer over patient records, documents, images, PDFs, and clinical data stores with enterprise access controls. | Whether the project uses Agent Search healthcare search, Healthcare API, Healthcare Data Engine, Gemini models, Visual Q&A, or another Google Cloud service, because data, pricing, and risk controls differ. | 6 official sources |
Jump to this category on the comparison page
Current search demand around Caris Life Sciences overlaps with Caris testing, precision oncology companies, precision medicine companies, life sciences labs, and portal or access checks. Compare Caris in the context of oncology data, molecular profiling, and tumor board workflow.
oncology AI tools · laboratory AI tools · ai for clinical trial matching · best ai model for medical data analysis 2025 · ai for medical affairs
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
FDA 510(k)-cleared sepsis test that runs on the Cytovale System and returns an IntelliSep Index band for adult ED patients with signs or suspicion of infection.
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.
Cloud-based Philips Cardiologs platform that uses deep-learning ECG analysis to support qualified clinicians reviewing Holter and ambulatory ECG recordings.
AI-enabled precision medicine platform spanning molecular testing, multimodal data, clinical assistants, care pathways, imaging insights, and trial matching.
Tempus generative AI assistant for querying clinical, molecular, imaging, EHR, and research data inside precision-medicine workflows.
AI-driven precision medicine platform for analyzing complex genomic, radiomic, and multimodal healthcare data.
Guardant Health AI and machine-learning portfolio for precision oncology data and multimodal real-world evidence workflows.
Multimodal AI prostate cancer test that analyzes digital pathology and clinical data to support risk stratification and treatment-personalization decisions.
AI-based prostate cancer mapping software that combines MRI, biopsy, pathology, PSA, and deep learning to generate patient-specific cancer estimation maps.
Clinical-trial AI company using disease-specific machine learning models to generate participant-level digital twins for trial analysis.
Biology-focused AI agent platform for drug discovery and development workflows using multimodal patient data and specialized biomedical AI skills.
Precision medicine company applying molecular science and AI to oncology testing, data, and treatment-insight workflows.
Oncology-specific clinical decision support that surfaces evidence-based regimens, biomarkers, clinical trials, and site preferences at the point of care.
Health data and analytics platform using AI to clean, query, analyze, and generate evidence from large linked real-world healthcare datasets.
Clinical-trial acceleration platform that applies AI to structured and unstructured clinical data for cohort discovery and patient matching.
Clinical AI platform that reads medical records to support trial screening, registry abstraction, and real-world evidence workflows.
Real-world data and analytics platform that supports clinical trial design, feasibility, site identification, recruitment planning, and evidence generation.
Clinical trial AI and analytics suite from Medidata that supports study design, feasibility, enrollment risk, data quality, operational monitoring, and integrated evidence workflows.
Oncology real-world data and AI platform company with products for evidence generation, clinical trials, commercial strategy, and CancerLinQ care insights.
Modular real-world evidence platform for turning real-world data into transparent, reproducible, decision-grade evidence.
Multimodal real-world evidence platform that applies human and AI intelligence to longitudinal EHR and other clinical data.
Precision medicine and clinical AI platform that pairs multimodal real-world patient data with validated algorithms for research, development, and evidence workflows.
AI-enabled in vitro diagnostic test that combines biomarkers and clinical variables to stratify kidney disease progression risk.
Home kidney-testing service that uses a smartphone app, test kit, colorimetric analysis, computer vision, and AI to measure urine albumin, creatinine, and ACR.
AI-powered CKD progression risk algorithm that uses standard demographic and lab parameters to produce kidney-function decline risk scores and clinical decision support.
Precision oncology platform for scaling hereditary cancer risk assessment, genetic testing workflows, patient navigation, and genomics-driven cancer prevention programs.
Blood-based colorectal cancer screening program built on Freenome's multiomics platform, which combines genomic, epigenomic, proteomic, computational-biology, and machine-learning signals.
Prescription multi-cancer early detection test from GRAIL that uses cell-free DNA methylation and machine learning to screen for cancer signals across more than 50 cancer types.
Precision neurology platform for Parkinson's disease that combines StrivePD app data, Apple Watch symptom measures, clinician dashboards, clinical-trial support, and an AI companion.
Google Cloud healthcare search capability for building governed search and generative-answer applications across FHIR data and linked clinical documents.
19 products
Clinical evidence and questions
Medium to high risk
24 products
Clinical documentation and scribes
Lower to medium risk
85 products
Medical imaging and radiology
High risk
19 products
Digital pathology
High risk
19 products
Surgery and procedural intelligence
High risk
57 products
Clinical operations and revenue cycle
Medium risk